ivabradine (generic tablets) — Cigna
Heart failure
Initial criteria
- Patient age ≥ 18 years
- Left ventricular ejection fraction (LVEF) ≤ 35% currently or prior to initiation of ivabradine therapy
- Patient is in normal sinus rhythm or sinus tachycardia with a resting heart rate ≥ 70 beats per minute
- Patient meets ONE of the following (i or ii): i. Patient has tried or is currently receiving one beta blocker for heart failure treatment OR ii. Patient has a contraindication to use of beta blocker therapy
- Medication is prescribed by or in consultation with a cardiologist
Approval duration
1 year